Mergers & Acquisitions
Jun. 21, 2013
Dealmakers
A roundup of recent mergers and acquisitions and financing activity and the lawyers involved.
O'Melveny advises Progenics Pharmaceuticals Inc. in planned stock offering
O'Melveny & Myers LLP is representing Tarrytown, N.Y.-based biopharmaceutical firm Progenics Pharmaceuticals Inc., which announced a planned public offering of common stock on Thursday.
Pricing information was not disclosed, but in a release the company indicated that a shelf registration statement been approved by the Securities ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In